Drugs / Fluzone Quadrivalent vaccine

Trials 7 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 12 trials
Phase 1 NCT03898986 Oct 2019 → Dec 2023 influenza Stanford University Completed No outcome recorded
Phase 1 NCT03088904 Oct 2014 → Dec 2018 influenza Stanford University Completed No outcome recorded
Phase 45 trials
Phase 4 NCT04551677 Sep → Dec 2020 Sanofi Pasteur, a Sanofi Company Completed No outcome recorded
Phase 4 NCT04109222 Sep → Dec 2019 influenza Sanofi Pasteur, a Sanofi Company Completed No outcome recorded
Phase 4 NCT03617523 Sep → Nov 2018 influenza Sanofi Pasteur, a Sanofi Company Completed No outcome recorded
Phase 4 NCT03308825 Sep → Nov 2017 influenza Sanofi Pasteur, a Sanofi Company Completed No outcome recorded
Phase 4 NCT02258334 Oct → Nov 2014 influenza Sanofi Pasteur, a Sanofi Company Completed No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT02290509 Comparator Oct 2014 → May 2015 influenza Protein Sciences Corporation Completed No outcome recorded

Evidence & citations 6 cited values

Every value below carries the sentence it was read from. 9 sources stand behind the page.

FieldValueCited text
Known as Fluzone Quadrivalent vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT02258334
5

NCT03308825

NCT03088904

NCT04109222

NCT03617523

NCT04551677

Known as Fluzone Quadrivalent “Fluzone® Quadrivalent” NCT04551677
Known as Fluzone Quadrivalent, No Preservative “Fluzone® Quadrivalent, No Preservative” NCT04109222
Known as Inactivated Influenza Vaccine (IIV4) ClinicalTrials.gov intervention name — accepted as the source's own label NCT03898986
1

NCT02290509

Modality Vaccine “a standard-dose, egg-grown, quadrivalent-inactivated influenza vaccine (IIV4)” PMID 28968871 Dec 2017
Route Intramuscular “0.5 mL, IntramuscularNCT02258334